185 related articles for article (PubMed ID: 12456941)
1. Severe hypersomnolence after pituitary/hypothalamic surgery in adolescents: clinical characteristics and potential mechanisms.
Snow A; Gozal E; Malhotra A; Tiosano D; Perlman R; Vega C; Shahar E; Gozal D; Hochberg Z; Pillar G
Pediatrics; 2002 Dec; 110(6):e74. PubMed ID: 12456941
[TBL] [Abstract][Full Text] [Related]
2. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
[TBL] [Abstract][Full Text] [Related]
3. Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma.
Tachibana N; Taniike M; Okinaga T; Ripley B; Mignot E; Nishino S
Sleep Med; 2005 Nov; 6(6):567-9. PubMed ID: 16084764
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
Compta Y; Santamaria J; Ratti L; Tolosa E; Iranzo A; Muñoz E; Valldeoriola F; Casamitjana R; Ríos J; Marti MJ
Brain; 2009 Dec; 132(Pt 12):3308-17. PubMed ID: 19858078
[TBL] [Abstract][Full Text] [Related]
5. Sleep in children with neoplasms of the central nervous system: case review of 14 children.
Rosen GM; Bendel AE; Neglia JP; Moertel CL; Mahowald M
Pediatrics; 2003 Jul; 112(1 Pt 1):e46-54. PubMed ID: 12837905
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia.
Liguori C; Romigi A; Mercuri NB; Nuccetelli M; Izzi F; Albanese M; Sancesario G; Martorana A; Sancesario GM; Bernardini S; Marciani MG; Placidi F
J Neurol; 2014 Sep; 261(9):1832-6. PubMed ID: 25119837
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?
Baumann C; Ferini-Strambi L; Waldvogel D; Werth E; Bassetti CL
J Neurol; 2005 Feb; 252(2):139-45. PubMed ID: 15729517
[TBL] [Abstract][Full Text] [Related]
8. Patients cured from craniopharyngioma or nonfunctioning pituitary macroadenoma (NFMA) suffer similarly from increased daytime somnolence despite normal sleep patterns compared to healthy controls.
van der Klaauw AA; Biermasz NR; Pereira AM; van Kralingen KW; Dekkers OM; Rabe KF; Smit JW; Romijn JA
Clin Endocrinol (Oxf); 2008 Nov; 69(5):769-74. PubMed ID: 18435832
[TBL] [Abstract][Full Text] [Related]
9. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness.
Müller HL; Handwerker G; Gebhardt U; Faldum A; Emser A; Kolb R; Sörensen N
Cancer Causes Control; 2006 May; 17(4):583-9. PubMed ID: 16596314
[TBL] [Abstract][Full Text] [Related]
10. Low levels of ventricular CSF orexin/hypocretin in advanced PD.
Drouot X; Moutereau S; Nguyen JP; Lefaucheur JP; Créange A; Remy P; Goldenberg F; d'Ortho MP
Neurology; 2003 Aug; 61(4):540-3. PubMed ID: 12939433
[TBL] [Abstract][Full Text] [Related]
11. Excessive daytime sleepiness in adults with brain injuries.
Masel BE; Scheibel RS; Kimbark T; Kuna ST
Arch Phys Med Rehabil; 2001 Nov; 82(11):1526-32. PubMed ID: 11689971
[TBL] [Abstract][Full Text] [Related]
12. Sleep-wake and melatonin pattern in craniopharyngioma patients.
Pickering L; Jennum P; Gammeltoft S; Poulsgaard L; Feldt-Rasmussen U; Klose M
Eur J Endocrinol; 2014 Jun; 170(6):873-84. PubMed ID: 24682900
[TBL] [Abstract][Full Text] [Related]
13. [Excessive daytime sleepiness and low CSF orexin-A/hypocretin-I levels in a patient with probable progressive supranuclear palsy].
Hattori Y; Hattori T; Mukai E; Mori H; Mizuno Y; Kayukawa Y; Okada T; Kanbayashi T
No To Shinkei; 2003 Dec; 55(12):1053-6. PubMed ID: 14870576
[TBL] [Abstract][Full Text] [Related]
14. A hypersomnolent girl with decreased CSF hypocretin level after removal of a hypothalamic tumor.
Arii J; Kanbayashi T; Tanabe Y; Ono J; Nishino S; Kohno Y
Neurology; 2001 Jun; 56(12):1775-6. PubMed ID: 11425955
[No Abstract] [Full Text] [Related]
15. Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness.
Constantinescu CS; Niepel G; Patterson M; Judd A; Braitch M; Fahey AJ; Harikrishnan S; Edwards LJ; Tench CR; Bennett GW; Ghatei M
J Neurol Sci; 2011 Aug; 307(1-2):127-31. PubMed ID: 21605873
[TBL] [Abstract][Full Text] [Related]
16. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
17. Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome.
Igarashi N; Tatsumi K; Nakamura A; Sakao S; Takiguchi Y; Nishikawa T; Kuriyama T
Chest; 2003 Oct; 124(4):1381-5. PubMed ID: 14555569
[TBL] [Abstract][Full Text] [Related]
18. Association of CSF orexin-A levels and nocturnal sleep stability in patients with hypersomnolence.
Barateau L; Lopez R; Chenini S; Rassu AL; Scholz S; Lotierzo M; Cristol JP; Jaussent I; Dauvilliers Y
Neurology; 2020 Nov; 95(21):e2900-e2911. PubMed ID: 32873687
[TBL] [Abstract][Full Text] [Related]
19. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
[TBL] [Abstract][Full Text] [Related]
20. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions.
Kato T; Kanbayashi T; Yamamoto K; Nakano T; Shimizu T; Hashimoto T; Ikeda S
Intern Med; 2003 Aug; 42(8):743-5. PubMed ID: 12924505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
